Detalles de la búsqueda
1.
Polyketide synthase positive Escherichia coli one-time measurement in stool is not informative of colorectal cancer risk in a screening setting.
J Pathol
; 263(2): 217-225, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38551073
2.
Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression.
Int J Cancer
; 146(7): 1979-1992, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31411736
3.
Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study.
BMC Gastroenterol
; 19(1): 146, 2019 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31420015
4.
Consensus molecular subtype classification of colorectal adenomas.
J Pathol
; 246(3): 266-276, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29968252
5.
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify.
Mol Cell Proteomics
; 16(10): 1850-1863, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28747380
6.
Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.
Br J Cancer
; 115(12): 1565-1574, 2016 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27855440
7.
Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis.
Ann Surg
; 263(1): 138-45, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25563886
8.
Expression of apoptosis regulating proteins identifies stage II and III colon cancer patients with high risk of recurrence.
J Surg Oncol
; 109(3): 255-65, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24249458
9.
Lumican and versican are associated with good outcome in stage II and III colon cancer.
Ann Surg Oncol
; 20 Suppl 3: S348-59, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22711178
10.
BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain.
J Pathol
; 226(3): 442-50, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22009326
11.
TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
Gut
; 61(11): 1568-75, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22207630
12.
Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
Gut
; 61(6): 855-64, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21890811
13.
Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case-Control Study.
Cancer Res Commun
; 3(11): 2292-2301, 2023 11 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37921412
14.
Cell cycle proteins predict recurrence in stage II and III colon cancer.
Ann Surg Oncol
; 19 Suppl 3: S682-92, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22311118
15.
Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
Inflamm Bowel Dis
; 28(9): 1309-1320, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35554535
16.
High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence.
Sci Rep
; 12(1): 12174, 2022 07 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35842496
17.
Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer.
Eur J Cancer
; 144: 91-100, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33341450
18.
Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases.
EBioMedicine
; 70: 103498, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34333237
19.
Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression.
Tumour Biol
; 31(2): 89-96, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20358421
20.
Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis.
Oncoimmunology
; 9(1): 1832761, 2020 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33101778